Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference

November 30, 2022

https://www.globenewswire.com/news-release/2022/11/30/2564801/0/en/Eliem-Therapeutics-at-the-5th-Annual-Evercore-ISI-HealthCONx-Virtual-Conference.html

SEATTLE and CAMBRIDGE, United Kingdom, Nov. 30, 2022 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq:ELYM), a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems, today announced that Bob Azelby, Eliem’s president and chief executive officer, will present at the 5th Annual Evercore ISI HealthCONx Virtual Conference being held virtually on Thursday, December 1, 2022 at 11:40 AM ET.

Read more at globenewswire.com

Related news for (ELYM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.